Using cutoff values of 40%, 50%, and 50% positive tumor cells for MYC, BCL-2, and BCL-6, respectively, 108 (55.4%) were positive for MYC, 129 (66.2%) cases were positive for BCL-2, and 115 (58.9%) cases were positive for BCL-6. The gene discussed is BCL2; the disease is neoplasm.